1. Home
  2. SUZ vs RDY Comparison

SUZ vs RDY Comparison

Compare SUZ & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Suzano S.A.

SUZ

Suzano S.A.

HOLD

Current Price

$9.64

Market Cap

10.8B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$12.93

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUZ
RDY
Founded
1924
1984
Country
Brazil
India
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
11.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SUZ
RDY
Price
$9.64
$12.93
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.90
AVG Volume (30 Days)
2.2M
1.2M
Earning Date
02-11-2026
01-21-2026
Dividend Yield
1.90%
0.55%
EPS Growth
61.72
9.95
EPS
0.99
0.79
Revenue
$9,603,137,110.00
$3,851,623,984.00
Revenue This Year
$7.05
$6.12
Revenue Next Year
$12.79
$2.58
P/E Ratio
$9.73
$16.20
Revenue Growth
17.39
14.10
52 Week Low
$8.41
$12.26
52 Week High
$10.86
$16.17

Technical Indicators

Market Signals
Indicator
SUZ
RDY
Relative Strength Index (RSI) 59.25 27.01
Support Level $9.52 $13.15
Resistance Level $9.81 $13.30
Average True Range (ATR) 0.15 0.17
MACD 0.03 -0.10
Stochastic Oscillator 74.64 0.40

Price Performance

Historical Comparison
SUZ
RDY

About SUZ Suzano S.A.

Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: